JPRN-UMIN000011500已完成1 期
Brachytherapy using linked-seed for prostate cancer with one intermediate risk factor -multicenter phase I/II trial- - Linked-seed brachytherapy for prostate cancer with one intermediate risk factor
Osaka University Graduate School of Medicine, Radiation Oncology0 个研究点目标入组 25 人开始时间: 2013年8月16日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •1) active other cancer 2) uncontrollable diabetes millitus 3) ubable to stop anticoagulation drug 4) significant psycologic disease 5) collagen disease 6) judged as inappropriate by the dedicated physician
研究者
相似试验
招募中
不适用
Focal Brachytherapy for localized prostate cancer diagnosed by saturation biopsyprostate cancerJPRN-UMIN000044790ara Medical University35
招募中
2 期
Salvage focal therapy for prostate cancer using low-dose-rate brachytherapyprostate cancerJPRN-UMIN000051113Saitama Cancer Center100
招募中
2 期
Primary focal therapy for prostate cancer using low-dose-rate brachytherapyprostate cancerJPRN-UMIN000050997Saitama Cancer Center200
已完成
不适用
Focal therapy of localized prostate cancer using mpMRI/TRUS-guided high intensity focused ultrasound (HIFU) technologyC61Malignant neoplasm of prostateDRKS00007105Klinik für Urologie, Universitätsmedizin Mannheim50
已完成
不适用
Implantation of marker seeds into the prostate; to improve quality of radiotherapy delivery and to allow dose escalation for men with localised prostate cancerocalised prostate cancer in men.Inter-fraction prostate motion and motion of prostate relative to its position at simulation are potential sources of systematic treatment error.Localised prostate cancer in men.Inter-fraction prostate motion and motion of prostate relative to its position at simulation are potential sources of systematic treatment error.Cancer - ProstateACTRN12607000335493Dr George Hruby20